Join the Shock group to help and get support from people like you.
Shock News
FDA Approves Giapreza (angiotensin II) to Treat Dangerously Low Blood Pressure
December 21, 2017 – The U.S. Food and Drug Administration today approved Giapreza (angiotensin II) injection for intravenous infusion to increase blood pressure in adults with septic or other...
Further information
Related drug support groups
methylprednisolone, hydrocortisone, Medrol, cortisone, dexamethasone, phenylephrine, epinephrine, norepinephrine